• Licensing medicines for children. London. British Paediatric Association, May
  • 2
    Turner S, Gill A, Nunn AJ, Choonara I, Hewitt B. Use of ‘off-label’ and unlicensed drugs in paediatric intensive care unit. Lancet 1996;347, 549550
  • 3
    Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed drug use on paediatric wards. Br Med J 1998;316, 343345
  • 4
    Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999;80, F142F145
  • 5
    Turner S, Nunn AJ, Choonara I. Unlicensed drug use in children in the U.K. Paediatric Perinatal Drug Ther 1997;1, 5255
  • 6
    Appleton R, Sweeney A, Choonara I, Robson J, Molyneux E. Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus. Dev Med Child Neurol 1995;37, 682688
  • 7
    Hughes J, Gill A, Leach HJ,et al.A prospective study of the adverse effects of midazolam on withdrawal in critically ill children. Acta Paediatr 1994;83, 11941199
  • 8
    Note for guidance on clinical investigation of medicinal products in children, London. Medicines Control Agency, 1997.
  • 9
    Choonara I, Dunne J. Licensing of medicines. Arch Dis Child 1998;78, 402403
  • 10
    Collier J. Paediatric prescribing: using unlicensed drugs and medicines outside their licensed indications. Br J Clin Pharmacol 1999;48, 58
  • 11
    Impicciatore P, Choonara I. Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use. Br J Clin Pharmacol 1999;48, 1518
  • 12
    Guidelines for the ethical conduct of medical research involving children, London. British Paediatric Association 1992.
  • 13
    Choonara I, Lawrence A, Michalkiewicz A, Bowhay A, Ratcliffe J. Morphine metabolism in neonates and infants. Br J Clin Pharmacol 1992;34, 434437
  • 14
    Burtin P, Jacqz-Aigrain E, Girard P,et al. Population pharmacokinetics of midazolam in neonates. Clin Pharmacol Ther 1994;56, 615625
  • 15
    Hain RDW, Hardcastle A, Pinkerton CR, Aherne GW. Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children. Arch Dis Child 1999;80(Suppl 1): A9
  • 16
    Hughes J, Gill AM, Mulhearn H, Powell E, Choonara I. Steady state plasma concentrations of midazolam in critically ill infants and children. Ann Pharmacother 1996;30, 2730
  • 17
    Barrett DA, Barker DP, Rutter N, Pawula M, Shaw PN. Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions. Br J Clin Pharmacol 1996;41, 531537
  • 18
    Choonara I, Gill A, Nunn A. Drug toxicity and surveillance in children. Br J Clin Pharmacol 1996;42, 407410
  • 19
    Fisher E, Siemes H, Pund R, Wittfoht W, Nau H. Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms; abnormal metabolite pattern associated with reversible hepatotoxicity. Epilepsia 1992;33, 165171
  • 20
    Weiss CF, Glazko AJ, Weston JK. Chloramphenicol in the newborn infant. N Engl J Med 1960;262, 787794
  • 21
    Penna A, Buchanan N. Paracetamol poisoning in children and hepatotoxicity. Br J Clin Pharmacol 1991;32, 143149
  • 22
    Ohnhaus EE, Breckenridge AM, Park BK. Urinary excretion of 6β-hydroxycortisol and the time course measurement of enzyme induction in man. Eur J Clin Pharmacol 1989;36, 3946
  • 23
    Levitsky LL, Schoeller DA, Lambert GH, Edidin DV,Effect of growth hormone therapy in growth hormone-deficient children on cytochrome P-450-dependent 3-N-demethylation of caffeine as measured by the caffeine 13CO2 breath test. Dev Pharmacol Ther 1989;12, 9095
  • 24
    Parker AC, Preston T, Heaf D, Kitteringham NR, Choonara I. Inhibition of caffeine metabolism by ciprofloxacin in children with cystic fibrosis as measured by the caffeine breath test. Br J Clin Pharmacol 1994;38, 573576
  • 25
    Parker AC, Pritchard P, Preston T, Smyth RL, Choonara I. Enhanced drug metabolism in young children with cystic fibrosis. Arch Dis Child 1997;77, 239241
  • 26
    Parker AC, Pritchard P, Preston T, Choonara I. Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath test. Br J Clin Pharmacol 1998;45, 176178
  • 27
    Wrighton SA, Stevens JC. The Human Hepatic Cytochromes P450 involved in drug metabolism. Crit Rev Toxicology 1992;22, 121
  • 28
    Breitkreutz J, Wessel T, Boos J. Dosage forms for peroral drug administration to children. Paediatric and Perinatal Drug Therapy 1999;3, 2533
  • 29
    Koren G, Barzilay Z, Greenwald M. Tenfold errors in administration of drug doses: a neglected iatrogenic disease in pediatrics. Pediatrics 1986;77, 848849
  • 30
    Roberts R, Maldonado S. FDA Center for Drug Evaluation and Research (CDER) Pediatric Plan and New Regulations. Drug Information Journal 1996;30, 11251127
  • 31
    Nahata MC. Licensing of Medicines for Children in the USA. Paediatric Perinatal Drug Ther 1997;1, 5051
  • 32
    Moore P. Children are not small adults. Lancet 1998;352, 630
  • 33
    Kearns G. The Paediatric Pharmacology Research Unit Network. Proof of Concept. Paediatric and Perinatal Drug Therapy 1999;3, 914
  • 34
    Brown EG, Choonara I. The safety of medicines used in children. Int J Pharmaceut Med 1998;12, 285288
  • 35
    Norris E, Marzouk O, Nunn AJ, McIntyre J, Choonara I. Respiratory depression in children receiving diazepam for acute seizures—a prospective study. Dev Med Child Neurol 1999;41, 340343